摘要 |
Disclosed are medicaments, pharmaceutical compositions, pharmaceutical kits, and methods based on combinations of a hepatitis C virus (HCV) protease inhibitor and an aldo-keto reductase (AKR) competitor, for concurrent or consecutive administration in treating, preventing, or ameliorating one or more symptoms of HCV, treating disorders associated with HCV, or inhibiting cathepsin activity in a subject. |
申请人 |
SCHERING CORPORATION;GHOSAL, ANIMA;KISHNANI, NARENDRA, S.;ALTON, KEVIN, B.;WHITE, RONALD, E. |
发明人 |
GHOSAL, ANIMA;KISHNANI, NARENDRA, S.;ALTON, KEVIN, B.;WHITE, RONALD, E. |